Knowledge

Hereditary multiple exostoses

Source đź“ť

327:
lengthening, corrective osteotomies, temporary hemiepiphysiodesis to correct angular joint deformities such as distal radius hemiepiphysiodesis and medial distal tibial hemiepiphysiodesis. Nevertheless, there is little evidence to support the ongoing pediatric orthopedic practice in hereditary multiple osteochondromas. Recent systematic reviews found insufficient evidence to prove that the ongoing surgical treatment of HMO improves function considerably or to prove that it impacts the quality of life of affected children. To enhance the amount of evidence in the medical literature certain recommendations have been put forward. The construction of well-designed prospective studies that can provide a more clear relationship between surgical procedures, patient characteristics and outcomes is on high demand. Otherwise, following the current study designs will continue to raise more questions than answers. Total hip arthroplasty has been used to remedy severe and painful HMO of the hip joint. Total hip arthroplasty in individuals with HMO is challenging because of distortion of anatomy and repeated surgeries performed to address complaints related to exostosis.
121:
of affected individuals have clinically manifest osteochondromas around the knee. Forearm involvement in HMO is considerable. Furthermore, short stature may occur and is generally disproportionate. Such manifestations usually result from disruption of physeal growth especially that osteochondromas typically arise at the metaphyseal ends of long bones in close proximity to the physis. Intra-articular osteochondromas of the hip can induce limitation of range of motion, joint pain and acetabular dysplasia. Likewise joint pain at other locations and neurovascular compression can occur. Furthermore, functional disability in regard to activities of daily living can be a presenting feature. Spinal deformity pain or neurological compromise should arouse suspicion of involvement of the vertebrae.
213:
never manifesting it. The 96% penetrance figure comes from only one study. Other studies have observed both incomplete and variable penetrance but without calculating the % penetrance, e.g. In both the aforementioned studies the symptomless individuals carrying the faulty gene were predominantly female, leading to speculation that incomplete penetrance is more likely to be exhibited in females. Indeed, other work has shown that boys/men tend to have worse disease than females, as well as that the number of exostoses in affected members of the same family can vary greatly. It is also possible for females to be severely affected. Severity of symptoms varies between individuals, even in the same family.
383: 407: 64: 347: 318:
variants are known to cause HMO namely EXT1 and EXT2. A combination of sequence analysis and deletion analysis of the entire coding regions of both EXT1 and EXT2 detects pathogenic variants in 70–95% of affected individuals. The hallmark of radiographic diagnosis is the presence of osteochondromas at the metaphyseal ends of long bones in which the cortex and medulla of the osteochondroma represent a continuous extension of the host bone. This is readily demonstrable in radiographs of the knees.
96:. Additional sites of occurrence include on flat bones such as the pelvic bone and scapula. The distribution and number of these exostoses show a wide diversity among affected individuals. Exostoses usually present during childhood. The vast majority of affected individuals become clinically manifest by the time they reach adolescence. The incidence of hereditary multiple exostoses is around 1 in 50,000 individuals. Hereditary multiple osteochondromas is the preferred term used by the 371: 395: 40: 212:
and prenatal diagnosis are available to determine if their unborn child has inherited the disease. HME has a 96% penetrance, which means that if the affected gene is indeed transmitted to a child, the child will have a 96% of actually manifesting the disease, and 4% chance of having the disease but
162:
hereditary disorder. This means that a patient with HME has a 50% chance of transmitting this disorder to his or her children. Most individuals with HME have a parent who also has the condition, however, approximately 10% -20% of individuals with HME have the condition as a result of a spontaneous
120:
may be the first presenting symptom. Multiple deformities can arise, namely coronal plane deformities around the knees, ankles, shoulders, elbows, and wrists. For example, genu valgum (knock knees), ankle valgus, ulnar bowing and shortening, and radial head subluxation are encountered. The majority
129:
According to self-reports, a far majority of patients experience pain, and about half experience generalized pain. Individuals who had HME-related complications were five times more likely to have pain, while those who had surgery were 3.8 times more likely to have pain. No differences were found
317:
The diagnosis of HMO is based upon establishing an accurate correlation between the above-mentioned clinical features and the characteristic radiographic features. Family history can provide an important clue to the diagnosis. This is supplemented by testing for the two genes in which pathogenic
299:
HME can lead to the shortening and bowing of bones; affected individuals often have a short stature. Depending on their location the exostoses can cause problems including: pain or numbness from nerve compression, vascular compromise, inequality of limb length, irritation of tendon and muscle,
326:
The indications for surgical intervention in individuals with HMO remain unclear and vary greatly across the medical literature. In general surgical treatment of HMO includes one or more of the following procedures: ostechondroma excision, gradual or acute bone lengthening such as the ulna
308:
as an adult. Problems may be had in later life and these could include weak bones and nerve damage. The reported rate of transformation ranges from as low as 0.57% to as high as 8.3% of people with HME. Some authors have described an association between HME and the presence of popliteal
1379:
Parada Duarte O, Arambula Neira J, Castillo Herazo V, Oviedo Lara M, López Polanco A, Durán Omaña A, Herrera Ortiz AF. Popliteal artery pseudoaneurysm caused by non–penetrating trauma in a patient with hereditary multiple osteochondromatosis. Radiology Case Reports.2021;17(1):185-189.
811:
Wu YQ, Heutink P, de Vries BB, Sandkuijl LA, van den Ouweland AM, Niermeijer MF, Galjaard H, Reyniers E, Willems PJ, Halley DJ (1994). "Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11".
1483: 1468: 1065:
Faiyaz-Ul-Haque M, Ahmad W, Zaidi SH, et al. (August 2004). "Novel mutations in the EXT1 gene in two consanguineous families affected with multiple hereditary exostoses (familial osteochondromatosis)".
252: 847:
Le Merrer M, Legeai-Mallet L, Jeannin PM, Horsthemke B, Schinzel A, Plauchu H, Toutain A, Achard F, Munnich A, Maroteaux P (1994). "A gene for hereditary multiple exostoses maps to chromosome 19p".
189:
Mutations in these genes typically lead to the synthesis of a truncated EXT protein which does not function normally. It is known that EXT proteins are important enzymes in the synthesis of
346: 193:; however, the exact mechanism by which altered synthesis of heparan sulfate that could lead to the abnormal bone growth associated with HME is unclear. It is thought that normal 146:
used a mouse model of HME to observe cognitive function. The findings indicated that the mutant mice endorsed three autistic characteristics: social impairment, impairments in
1112:
Porter DE, Lonie L, Fraser M, et al. (September 2004). "Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study".
92:) in relation to the ends of long bones of the lower limbs such as the femurs and tibias and of the upper limbs such as the humeri and forearm bones. They are also known as 304:
as well as a limited range of motion at the joints upon which they encroach. A person with HME has an increased risk of developing a rare form of bone cancer called
406: 1967: 1022:
Legeai-Mallet L, Munnich A, Maroteaux P, Le Merrer M (July 1997). "Incomplete penetrance and expressivity skewing in hereditary multiple exostoses".
625:
Alvarez, CM; De Vera, MA; Heslip, TR; Casey, B (September 2007). "Evaluation of the anatomic burden of patients with hereditary multiple exostoses".
197:
proliferation and differentiation may be affected, leading to abnormal bone growth. Since the HME genes are involved in the synthesis of a glycan (
2070: 1586: 2048: 382: 248:
of the long bones. Typically five or six exostoses are found in upper and lower limbs. Image depicts adult regrowth after knee replacement.
2172: 143: 1297: 2087: 1648: 108:. The risk that people with hereditary multiple osteochondromas have a 1 in 20 to 1 in 200 lifetime risk of developing sarcomas. 1671: 770:
Cook A, Raskind W, Blanton SH, Pauli RM, Gregg RG, Francomano CA, Puffenberger E, Conrad EU, Schmale G, Schellenberg G (1993).
276: 267: 668:
Darilek S, Wicklund C, Novy D, Scott A, Gambello M, Johnston D, Hecht J (May 2005). "Hereditary multiple exostosis and pain".
1209: 2021: 1995: 202: 2063: 1876: 1857: 1681: 1653: 1579: 1498: 2033: 2026: 1445: 1176: 2000: 446:"Current paediatric orthopaedic practice in hereditary multiple osteochondromas of the forearm: a systematic review" 594: 2078: 2056: 1625: 1572: 1744: 1676: 1134: 2106: 1749: 185:
which maps to the short arm of Chromosome 19 (though its exact location has yet to be precisely determined)
2182: 2141: 2083: 892:
Zak BM, Crawford BE, Esko JD (2002). "Hereditary multiple exostoses and heparan sulfate polymerization".
370: 142:-like social problems in their children. To explore those observations more deeply, a 2012 study by the 2115: 1911: 1866: 2079: 1987: 1972: 861: 97: 63: 2151: 1512: 105: 1960: 1897: 502:"Hip joint osteochondroma: systematic review of the literature and report of three further cases" 394: 301: 147: 1325: 1196: 2177: 1927: 1848: 856: 256: 2091: 1977: 1765: 1643: 1603: 1595: 724: 713:"Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate" 159: 8: 2131: 2016: 1947: 1794: 1732: 1487: 1195:
Davies, A. Mark; Pettersson, Holger (2002). Pettersson, Holger; Ostensen, Harald (eds.).
47:
Photograph of the legs of a 26-year-old male showing multiple lumps leading to deformity.
728: 1934: 1492: 1419: 1394: 1243: 1226: 1147: 1091: 1047: 1035: 996: 971: 952: 788: 771: 747: 712: 693: 681: 650: 528: 501: 470: 445: 251: 130:
between males and females with respect to pain, surgery, or HME-related complications.
905: 1890: 1836: 1523: 1424: 1362: 1317: 1313: 1275: 1248: 1205: 1172: 1139: 1083: 1079: 1039: 1001: 944: 940: 909: 874: 829: 793: 752: 685: 642: 569: 533: 475: 444:
EL-Sobky, TA; Samir, S; Atiyya, AN; Mahmoud, S; Aly, AS; Soliman, R (21 March 2018).
255:
Skeleton of 92 year old woman with MHE who had knee replacements at age 70. See FIRS
52: 1395:"Bilateral total hip arthroplasty in a young man with hereditary multiple exostoses" 1171:(6th ed.). Philadelphia: Lippincott Williams & Wilkins. 2005. p. 263. 1095: 1051: 956: 697: 654: 500:
Makhdom, AM; Jiang, F; Hamdy, RC; Benaroch, TE; Lavigne, M; Saran, N (20 May 2014).
2136: 1914: 1825: 1770: 1739: 1414: 1406: 1357: 1352: 1340: 1309: 1238: 1151: 1129: 1121: 1075: 1031: 991: 983: 936: 901: 866: 821: 783: 742: 732: 677: 634: 523: 513: 465: 457: 57: 927:
Stieber JR, Dormans JP (2005). "Manifestations of hereditary multiple exostoses".
2126: 2119: 2111: 1955: 1922: 1704: 1552: 1517: 1125: 987: 638: 209: 198: 190: 208:
For individuals with HME who are considering starting a family, preimplantation
1885: 1831: 1785: 1699: 1691: 1608: 1528: 717:
Proceedings of the National Academy of Sciences of the United States of America
353: 305: 117: 93: 1477: 1381: 561: 2166: 1709: 1339:
Kivioja A, Ervasti H, Kinnunen J, Kaitila I, Wolf M, Böhling T (March 2000).
461: 357: 100:. A small percentage of affected individuals are at risk for development of 1410: 737: 2146: 1428: 1366: 1252: 1143: 1087: 1005: 948: 913: 756: 689: 646: 573: 537: 479: 1321: 1279: 1043: 878: 870: 833: 825: 797: 518: 1816: 1564: 241: 194: 182: 176: 1460: 1635: 1547: 846: 245: 163:
mutation and are thus the first person in their family to be affected.
1021: 772:"Genetic heterogeneity in families with hereditary multiple exostoses" 232:
is also the most commonly affected gene in patients of this disorder.
1812: 1663: 1617: 89: 560:
Wuyts, W; Schmale, GA; Chansky, HA; et al. (21 November 2013).
1775: 1944: 285: 101: 1506: 1503: 216:
Symptoms are more likely to be severe if the mutation is on the
1472: 1341:"Chondrosarcoma in a family with multiple hereditary exostoses" 292: 139: 85: 1266:
McBride WZ (September 1988). "Hereditary multiple exostoses".
1338: 279: 270: 240:
It is characterized by the growth of cartilage-capped benign
84:, is a disorder characterized by the development of multiple 412:
skeleton of 92-year old woman 20 years after hip replacement
166:
HME has thus far been linked with mutations in three genes:
1726: 929:
The Journal of the American Academy of Orthopaedic Surgeons
361: 170: 969: 810: 710: 443: 1064: 624: 499: 205:
according to the new CDG nomenclature suggested in 2009.
1204:. Geneva: World Health Organization. pp. 177, 189. 667: 1393:
Vaishya, R; Swami, S; Vijay, V; Vaish, A (5 Jan 2015).
769: 39: 1392: 1302:
The Journal of Bone and Joint Surgery. American Volume
1298:"The natural history of hereditary multiple exostoses" 894:
Biochimica et Biophysica Acta (BBA) - General Subjects
1345:
The Journal of Bone and Joint Surgery. British Volume
1169:
Turek's orthopaedics principles and their application
1114:
The Journal of Bone and Joint Surgery. British Volume
244:
around areas of active bone growth, particularly the
1450: 1295: 356:
causing deformity of the forearm (shortening of the
711:Irie F, Badie-Mahdavi H, Yamaguchi Y (March 2012). 559: 970:Jaeken J, Hennet T, Matthijs G, Freeze HH (2009). 1968:Autosomal recessive multiple epiphyseal dysplasia 1135:20.500.11820/8754788e-ceea-4613-8e65-60d34fcf9edc 1111: 335:HME is estimated to occur in 1 in 50,000 people. 2164: 1194: 138:Some parents of children with HME have observed 133: 1296:Schmale GA, Conrad EU, Raskind WH (July 1994). 1107: 1105: 891: 1291: 1289: 1017: 1015: 926: 2064: 1580: 620: 618: 616: 555: 553: 551: 549: 547: 439: 437: 435: 433: 431: 429: 427: 1332: 1218: 1102: 963: 920: 885: 495: 493: 491: 489: 1386: 1382:https://doi.org/10.1016/j.radcr.2021.10.025 1286: 1259: 1012: 840: 2071: 2057: 1594: 1587: 1573: 1446:GeneReviews: Hereditary Multiple Exostoses 1265: 804: 763: 613: 544: 424: 144:Sanford-Burnham Medical Research Institute 62: 38: 1418: 1356: 1242: 1224: 1198:Radiography of the Musculoskeletal System 1133: 995: 860: 787: 746: 736: 527: 517: 486: 469: 1163: 1161: 388:multiple osteochondromas around the knee 250: 2165: 1672:Spondyloepiphyseal dysplasia congenita 1190: 1188: 972:"CDG nomenclature: time for a change!" 376:multiple osteochondromas at the pelvis 2052: 1649:Jansen's metaphyseal chondrodysplasia 1568: 1158: 595:"Hereditary multiple osteochondromas" 568:. University of Washington, Seattle. 562:"Hereditary Multiple Osteochondromas" 1996:Rhizomelic chondrodysplasia punctata 338: 203:congenital disorder of glycosylation 116:A noticeable lump in relation to an 1682:Otospondylomegaepiphyseal dysplasia 1654:Schmid metaphyseal chondrodysplasia 1185: 74:Hereditary multiple osteochondromas 25:Hereditary multiple osteochondromas 13: 1231:American Journal of Human Genetics 1036:10.1111/j.1399-0004.1997.tb02508.x 776:American Journal of Human Genetics 682:10.1097/01.bpo.0000150813.18673.ad 235: 14: 2194: 2173:Proteoglycan metabolism disorders 1439: 670:Journal of Pediatric Orthopaedics 2152:MPS IX: Hyaluronidase deficiency 2022:Short rib – polydactyly syndrome 1314:10.2106/00004623-199407000-00005 1080:10.1111/j.1399-0004.2004.00275.x 941:10.5435/00124635-200503000-00004 405: 393: 381: 369: 345: 2142:MPS VI: Maroteaux-Lamy syndrome 2027:Majewski's polydactyly syndrome 1373: 1227:"Hereditary multiple exostoses" 1058: 330: 173:which maps to chromosome 8q24.1 111: 1358:10.1302/0301-620X.82B2.0820261 704: 661: 601:. National Library of Medicine 587: 1: 1801:Hereditary multiple exostoses 1745:Polyostotic fibrous dysplasia 1677:Multiple epiphyseal dysplasia 1553:Hereditary multiple exostoses 906:10.1016/S0304-4165(02)00402-6 417: 360:with secondary bowing of the 191:heparan sulfate proteoglycans 134:Possible connection to autism 82:hereditary multiple exostoses 33:Hereditary multiple exostoses 2132:MPS III: Sanfilippo syndrome 2034:LĂ©ri–Weill dyschondrosteosis 1126:10.1302/0301-620x.86b7.14815 988:10.1016/j.bbadis.2009.08.005 639:10.1097/BLO.0b013e3181334b51 321: 312: 7: 263:Most common locations are: 201:), HME may be considered a 153: 150:, and repetitive behavior. 88:osteocartilaginous masses ( 10: 2199: 2080:Lysosomal storage diseases 2001:Conradi–HĂĽnermann syndrome 1626:Camurati–Engelmann disease 400:CT of osteochondroma in MO 2099: 2009: 1988:Chondrodysplasia punctata 1986: 1973:Atelosteogenesis, type II 1943: 1910: 1875: 1856: 1847: 1811: 1784: 1764: 1718: 1690: 1662: 1634: 1616: 1602: 1538: 1454: 1268:American Family Physician 98:World Health Organization 51: 46: 37: 29: 24: 2137:MPS IV: Morquio syndrome 1750:McCune–Albright syndrome 849:Human Molecular Genetics 814:Human Molecular Genetics 257:Colorado Mesa University 106:malignant transformation 2127:MPS II: Hunter syndrome 2088:carbohydrate metabolism 1898:Thanatophoric dysplasia 1411:10.1136/bcr-2014-207853 738:10.1073/pnas.1117881109 506:Advances in Orthopedics 148:ultrasonic vocalization 124: 2116:Hurler–Scheie syndrome 1867:Antley–Bixler syndrome 1849:Growth factor receptor 1596:Osteochondrodysplasias 976:Biochim. Biophys. Acta 462:10.1051/sicotj/2018002 260: 16:Rare skeletal disorder 2147:MPS VII: Sly syndrome 2092:Mucopolysaccharidoses 1978:Diastrophic dysplasia 1644:Metaphyseal dysplasia 627:Clin Orthop Relat Res 254: 302:Madelung's deformity 2017:Fibrochondrogenesis 1795:osteochondromatosis 1733:Boomerang dysplasia 871:10.1093/hmg/3.5.717 826:10.1093/hmg/3.1.167 729:2012PNAS..109.5052I 519:10.1155/2014/180254 179:which maps to 11p13 2183:Skeletal disorders 1935:Hypochondrogenesis 1539:External resources 1225:CANNON JF (1954). 261: 160:autosomal dominant 2160: 2159: 2046: 2045: 2042: 2041: 1906: 1905: 1891:Hypochondroplasia 1837:Maffucci syndrome 1760: 1759: 1562: 1561: 1405:: bcr2014207853. 1211:978-92-4-154555-6 1068:Clinical Genetics 1024:Clinical Genetics 339:Additional images 309:pseudoaneurysms. 220:gene rather than 80:), also known as 71: 70: 19:Medical condition 2190: 2073: 2066: 2059: 2050: 2049: 1948:sulfation defect 1915:collagen disease 1854: 1853: 1826:enchondromatosis 1782: 1781: 1771:chondrodystrophy 1766:Chondrodysplasia 1740:Opsismodysplasia 1614: 1613: 1589: 1582: 1575: 1566: 1565: 1452: 1451: 1433: 1432: 1422: 1390: 1384: 1377: 1371: 1370: 1360: 1336: 1330: 1329: 1324:. Archived from 1293: 1284: 1283: 1263: 1257: 1256: 1246: 1222: 1216: 1215: 1203: 1192: 1183: 1182: 1165: 1156: 1155: 1137: 1109: 1100: 1099: 1062: 1056: 1055: 1019: 1010: 1009: 999: 967: 961: 960: 924: 918: 917: 889: 883: 882: 864: 862:10.1.1.1028.5356 844: 838: 837: 808: 802: 801: 791: 767: 761: 760: 750: 740: 708: 702: 701: 665: 659: 658: 622: 611: 610: 608: 606: 591: 585: 584: 582: 580: 557: 542: 541: 531: 521: 497: 484: 483: 473: 441: 409: 397: 385: 373: 349: 67: 66: 58:Medical genetics 42: 22: 21: 2198: 2197: 2193: 2192: 2191: 2189: 2188: 2187: 2163: 2162: 2161: 2156: 2120:Scheie syndrome 2112:Hurler syndrome 2095: 2077: 2047: 2038: 2005: 1982: 1956:Achondrogenesis 1939: 1923:Achondrogenesis 1902: 1871: 1843: 1807: 1773: 1769: 1756: 1719:Other/ungrouped 1714: 1705:Osteopoikilosis 1686: 1658: 1630: 1607: 1598: 1593: 1563: 1558: 1557: 1534: 1533: 1463: 1442: 1437: 1436: 1391: 1387: 1378: 1374: 1337: 1333: 1294: 1287: 1264: 1260: 1223: 1219: 1212: 1201: 1193: 1186: 1179: 1167: 1166: 1159: 1110: 1103: 1063: 1059: 1020: 1013: 968: 964: 925: 921: 890: 886: 845: 841: 809: 805: 768: 764: 709: 705: 666: 662: 623: 614: 604: 602: 593: 592: 588: 578: 576: 558: 545: 498: 487: 442: 425: 420: 413: 410: 401: 398: 389: 386: 377: 374: 365: 354:osteochondromas 350: 341: 333: 324: 315: 238: 236:Pathophysiology 210:genetic testing 199:heparan sulfate 156: 136: 127: 114: 104:as a result of 94:osteochondromas 61: 20: 17: 12: 11: 5: 2196: 2186: 2185: 2180: 2175: 2158: 2157: 2155: 2154: 2149: 2144: 2139: 2134: 2129: 2124: 2123: 2122: 2103: 2101: 2097: 2096: 2076: 2075: 2068: 2061: 2053: 2044: 2043: 2040: 2039: 2037: 2036: 2031: 2030: 2029: 2019: 2013: 2011: 2010:Other dwarfism 2007: 2006: 2004: 2003: 1998: 1992: 1990: 1984: 1983: 1981: 1980: 1975: 1970: 1965: 1964: 1963: 1952: 1950: 1941: 1940: 1938: 1937: 1932: 1931: 1930: 1919: 1917: 1908: 1907: 1904: 1903: 1901: 1900: 1895: 1894: 1893: 1886:Achondroplasia 1882: 1880: 1873: 1872: 1870: 1869: 1863: 1861: 1851: 1845: 1844: 1842: 1841: 1840: 1839: 1834: 1832:Ollier disease 1821: 1819: 1809: 1808: 1806: 1805: 1804: 1803: 1790: 1788: 1786:Osteochondroma 1779: 1762: 1761: 1758: 1757: 1755: 1754: 1753: 1752: 1742: 1737: 1736: 1735: 1722: 1720: 1716: 1715: 1713: 1712: 1707: 1702: 1700:Raine syndrome 1696: 1694: 1692:Osteosclerosis 1688: 1687: 1685: 1684: 1679: 1674: 1668: 1666: 1660: 1659: 1657: 1656: 1651: 1646: 1640: 1638: 1632: 1631: 1629: 1628: 1622: 1620: 1611: 1609:osteodystrophy 1604:Osteodysplasia 1600: 1599: 1592: 1591: 1584: 1577: 1569: 1560: 1559: 1556: 1555: 1543: 1542: 1540: 1536: 1535: 1532: 1531: 1520: 1509: 1495: 1480: 1464: 1459: 1458: 1456: 1455:Classification 1449: 1448: 1441: 1440:External links 1438: 1435: 1434: 1385: 1372: 1331: 1328:on 2014-09-20. 1285: 1258: 1217: 1210: 1184: 1177: 1157: 1101: 1057: 1011: 962: 919: 884: 839: 803: 762: 723:(13): 5052–6. 703: 660: 612: 586: 543: 485: 422: 421: 419: 416: 415: 414: 411: 404: 402: 399: 392: 390: 387: 380: 378: 375: 368: 366: 351: 344: 340: 337: 332: 329: 323: 320: 314: 311: 306:chondrosarcoma 297: 296: 289: 283: 274: 237: 234: 187: 186: 180: 174: 155: 152: 135: 132: 126: 123: 113: 110: 69: 68: 55: 49: 48: 44: 43: 35: 34: 31: 27: 26: 18: 15: 9: 6: 4: 3: 2: 2195: 2184: 2181: 2179: 2178:Rare diseases 2176: 2174: 2171: 2170: 2168: 2153: 2150: 2148: 2145: 2143: 2140: 2138: 2135: 2133: 2130: 2128: 2125: 2121: 2117: 2113: 2110: 2109: 2108: 2105: 2104: 2102: 2098: 2093: 2089: 2085: 2084:Inborn errors 2081: 2074: 2069: 2067: 2062: 2060: 2055: 2054: 2051: 2035: 2032: 2028: 2025: 2024: 2023: 2020: 2018: 2015: 2014: 2012: 2008: 2002: 1999: 1997: 1994: 1993: 1991: 1989: 1985: 1979: 1976: 1974: 1971: 1969: 1966: 1962: 1959: 1958: 1957: 1954: 1953: 1951: 1949: 1946: 1942: 1936: 1933: 1929: 1926: 1925: 1924: 1921: 1920: 1918: 1916: 1913: 1909: 1899: 1896: 1892: 1889: 1888: 1887: 1884: 1883: 1881: 1878: 1874: 1868: 1865: 1864: 1862: 1859: 1855: 1852: 1850: 1846: 1838: 1835: 1833: 1830: 1829: 1828: 1827: 1823: 1822: 1820: 1818: 1814: 1810: 1802: 1799: 1798: 1797: 1796: 1792: 1791: 1789: 1787: 1783: 1780: 1777: 1772: 1767: 1763: 1751: 1748: 1747: 1746: 1743: 1741: 1738: 1734: 1731: 1730: 1729: 1728: 1724: 1723: 1721: 1717: 1711: 1710:Osteopetrosis 1708: 1706: 1703: 1701: 1698: 1697: 1695: 1693: 1689: 1683: 1680: 1678: 1675: 1673: 1670: 1669: 1667: 1665: 1661: 1655: 1652: 1650: 1647: 1645: 1642: 1641: 1639: 1637: 1633: 1627: 1624: 1623: 1621: 1619: 1615: 1612: 1610: 1605: 1601: 1597: 1590: 1585: 1583: 1578: 1576: 1571: 1570: 1567: 1554: 1550: 1549: 1545: 1544: 1541: 1537: 1530: 1526: 1525: 1521: 1519: 1515: 1514: 1510: 1508: 1505: 1501: 1500: 1496: 1494: 1490: 1489: 1485: 1481: 1479: 1475: 1474: 1470: 1466: 1465: 1462: 1457: 1453: 1447: 1444: 1443: 1430: 1426: 1421: 1416: 1412: 1408: 1404: 1400: 1396: 1389: 1383: 1376: 1368: 1364: 1359: 1354: 1350: 1346: 1342: 1335: 1327: 1323: 1319: 1315: 1311: 1308:(7): 986–92. 1307: 1303: 1299: 1292: 1290: 1281: 1277: 1273: 1269: 1262: 1254: 1250: 1245: 1240: 1237:(4): 419–25. 1236: 1232: 1228: 1221: 1213: 1207: 1200: 1199: 1191: 1189: 1180: 1178:9780781742986 1174: 1170: 1164: 1162: 1153: 1149: 1145: 1141: 1136: 1131: 1127: 1123: 1120:(7): 1041–6. 1119: 1115: 1108: 1106: 1097: 1093: 1089: 1085: 1081: 1077: 1074:(2): 144–51. 1073: 1069: 1061: 1053: 1049: 1045: 1041: 1037: 1033: 1029: 1025: 1018: 1016: 1007: 1003: 998: 993: 989: 985: 981: 977: 973: 966: 958: 954: 950: 946: 942: 938: 935:(2): 110–20. 934: 930: 923: 915: 911: 907: 903: 900:(3): 346–55. 899: 895: 888: 880: 876: 872: 868: 863: 858: 855:(5): 717–22. 854: 850: 843: 835: 831: 827: 823: 820:(1): 167–71. 819: 815: 807: 799: 795: 790: 785: 781: 777: 773: 766: 758: 754: 749: 744: 739: 734: 730: 726: 722: 718: 714: 707: 699: 695: 691: 687: 683: 679: 676:(3): 369–76. 675: 671: 664: 656: 652: 648: 644: 640: 636: 632: 628: 621: 619: 617: 600: 596: 590: 575: 571: 567: 563: 556: 554: 552: 550: 548: 539: 535: 530: 525: 520: 515: 511: 507: 503: 496: 494: 492: 490: 481: 477: 472: 467: 463: 459: 455: 451: 447: 440: 438: 436: 434: 432: 430: 428: 423: 408: 403: 396: 391: 384: 379: 372: 367: 363: 359: 355: 348: 343: 342: 336: 328: 319: 310: 307: 303: 294: 290: 287: 284: 281: 278: 275: 272: 269: 266: 265: 264: 258: 253: 249: 247: 243: 233: 231: 227: 223: 219: 214: 211: 206: 204: 200: 196: 192: 184: 181: 178: 175: 172: 169: 168: 167: 164: 161: 151: 149: 145: 141: 131: 122: 119: 109: 107: 103: 99: 95: 91: 87: 83: 79: 75: 65: 59: 56: 54: 50: 45: 41: 36: 32: 28: 23: 1824: 1800: 1793: 1725: 1546: 1522: 1511: 1497: 1482: 1467: 1402: 1399:BMJ Case Rep 1398: 1388: 1375: 1351:(2): 261–6. 1348: 1344: 1334: 1326:the original 1305: 1301: 1274:(3): 191–2. 1271: 1267: 1261: 1234: 1230: 1220: 1197: 1168: 1117: 1113: 1071: 1067: 1060: 1027: 1023: 982:(9): 825–6. 979: 975: 965: 932: 928: 922: 897: 893: 887: 852: 848: 842: 817: 813: 806: 779: 775: 765: 720: 716: 706: 673: 669: 663: 630: 626: 603:. Retrieved 598: 589: 577:. Retrieved 565: 509: 505: 453: 449: 334: 331:Epidemiology 325: 316: 298: 262: 242:bone tumours 239: 229: 225: 221: 217: 215: 207: 188: 165: 157: 137: 128: 115: 112:Presentation 81: 77: 73: 72: 1817:enchondroma 1774:(including 1030:(1): 12–6. 782:(1): 71–9. 566:GeneReviews 195:chondrocyte 30:Other names 2167:Categories 2100:Catabolism 1636:Metaphysis 1548:Patient UK 1524:DiseasesDB 512:: 180254. 418:References 246:metaphysis 158:HME is an 1813:Chondroma 1664:Epiphysis 1618:Diaphysis 857:CiteSeerX 633:: 73–79. 352:Multiple 322:Treatment 313:Diagnosis 291:Proximal 118:extremity 90:exostoses 53:Specialty 1776:dwarfism 1429:25564594 1367:10755438 1253:14349947 1144:15446535 1096:10431219 1088:15253765 1052:44423092 1006:19765534 957:29077708 949:15850368 914:12417417 757:22411800 698:27884079 690:15832158 655:39999620 647:17589361 579:24 March 574:20301413 538:24963411 480:29565244 277:Proximal 154:Genetics 102:sarcomas 1961:type 1B 1945:SLC26A2 1518:D005097 1420:4289752 1322:8027127 1280:3046271 1244:1716573 1152:7129239 1044:9272707 997:3917312 879:8081357 834:8162019 798:8317501 789:1682231 748:3323986 725:Bibcode 605:14 July 599:Medline 529:4054980 471:5863686 450:Sicot-J 286:Humerus 1928:type 2 1912:COL2A1 1507:133701 1504:133700 1493:756.59 1427:  1417:  1365:  1320:  1278:  1251:  1241:  1208:  1175:  1150:  1142:  1094:  1086:  1050:  1042:  1004:  994:  955:  947:  912:  877:  859:  832:  796:  786:  755:  745:  696:  688:  653:  645:  572:  536:  526:  478:  468:  456:: 10. 358:Radius 293:fibula 268:Distal 140:autism 86:benign 60:  2107:MPS I 1877:FGFR3 1858:FGFR2 1529:33342 1478:Q78.6 1202:(PDF) 1148:S2CID 1092:S2CID 1048:S2CID 953:S2CID 694:S2CID 651:S2CID 295:(30%) 288:(50%) 282:(70%) 280:tibia 273:(70%) 271:femur 1727:FLNB 1513:MeSH 1499:OMIM 1488:9-CM 1425:PMID 1403:2015 1363:PMID 1318:PMID 1276:PMID 1249:PMID 1206:ISBN 1173:ISBN 1140:PMID 1084:PMID 1040:PMID 1002:PMID 980:1792 945:PMID 910:PMID 898:1573 875:PMID 830:PMID 794:PMID 753:PMID 686:PMID 643:PMID 607:2024 581:2018 570:PMID 534:PMID 510:2014 476:PMID 362:Ulna 230:ext1 226:ext3 222:ext2 218:ext1 183:EXT3 177:EXT2 171:EXT1 125:Pain 2086:of 1484:ICD 1469:ICD 1415:PMC 1407:doi 1353:doi 1310:doi 1239:PMC 1130:hdl 1122:doi 1076:doi 1032:doi 992:PMC 984:doi 937:doi 902:doi 867:doi 822:doi 784:PMC 743:PMC 733:doi 721:109 678:doi 635:doi 631:462 524:PMC 514:doi 466:PMC 458:doi 224:or 78:HMO 2169:: 2118:, 2114:, 2082:: 1551:: 1527:: 1516:: 1502:: 1491:: 1476:: 1473:10 1423:. 1413:. 1401:. 1397:. 1361:. 1349:82 1347:. 1343:. 1316:. 1306:76 1304:. 1300:. 1288:^ 1272:38 1270:. 1247:. 1233:. 1229:. 1187:^ 1160:^ 1146:. 1138:. 1128:. 1118:86 1116:. 1104:^ 1090:. 1082:. 1072:66 1070:. 1046:. 1038:. 1028:52 1026:. 1014:^ 1000:. 990:. 978:. 974:. 951:. 943:. 933:13 931:. 908:. 896:. 873:. 865:. 851:. 828:. 816:. 792:. 780:53 778:. 774:. 751:. 741:. 731:. 719:. 715:. 692:. 684:. 674:25 672:. 649:. 641:. 629:. 615:^ 597:. 564:. 546:^ 532:. 522:. 508:. 504:. 488:^ 474:. 464:. 452:. 448:. 426:^ 364:). 228:; 2094:) 2090:( 2072:e 2065:t 2058:v 1879:: 1860:: 1815:/ 1778:) 1768:/ 1606:/ 1588:e 1581:t 1574:v 1486:- 1471:- 1461:D 1431:. 1409:: 1369:. 1355:: 1312:: 1282:. 1255:. 1235:6 1214:. 1181:. 1154:. 1132:: 1124:: 1098:. 1078:: 1054:. 1034:: 1008:. 986:: 959:. 939:: 916:. 904:: 881:. 869:: 853:3 836:. 824:: 818:3 800:. 759:. 735:: 727:: 700:. 680:: 657:. 637:: 609:. 583:. 540:. 516:: 482:. 460:: 454:4 259:. 76:(

Index


Specialty
Medical genetics
Edit this on Wikidata
benign
exostoses
osteochondromas
World Health Organization
sarcomas
malignant transformation
extremity
autism
Sanford-Burnham Medical Research Institute
ultrasonic vocalization
autosomal dominant
EXT1
EXT2
EXT3
heparan sulfate proteoglycans
chondrocyte
heparan sulfate
congenital disorder of glycosylation
genetic testing
bone tumours
metaphysis

Colorado Mesa University
Distal
femur
Proximal

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑